Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,530,754
-
Share change
-
-11,562,674
-
Total reported value
-
$68,933,226
-
Put/Call ratio
-
47%
-
Price per share
-
$3.06
-
Number of holders
-
88
-
Value change
-
-$31,709,577
-
Number of buys
-
39
-
Number of sells
-
46
Institutional Holders of GALENA BIOPHARMA INC - COM (GALE) as of Q2 2014
As of 30 Jun 2014,
GALENA BIOPHARMA INC - COM (GALE) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,530,754 shares.
The largest 10 holders included
BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Smith Asset Management Group LP, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.